DOCSLIB.ORG

Hereditary Hemorrhagic Telangiectasia Clinical and Molecular Genetics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hereditary Hemorrhagic Telangiectasia Clinical and Molecular Genetics Hereditary Hemorrhagic Telangiectasia Clinical and Molecular Genetics Tom G.W. Letteboer ISBN: 978-90-5335-333-2 Author: Tom G.W. Letteboer Cover design: Wilmy Swaerdens, using painting from Nelleke Docter (Pimpelnell), called “The Family” Lay-out and printing: Simone Vinke, Ridderprint B.V., Ridderkerk, the Netherlands Hereditary Hemorrhagic Telangiectasia Clinical and Molecular Genetics Klinische en moleculair genetische aspecten van hereditaire hemorrhagische teleangiëctasieën (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof. dr. J.C. Stoof, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op woensdag 10 november 2010 des middags 12.45 uur door Thomas Gerrit Wim Letteboer geboren op 9 februari 1967 te Zwolle Promotor: Prof. dr. D. Lindhout Co-promotoren: Dr. C.J.J. Westermann Dr. J.K. Ploos van Amstel The author gratefully acknowledges financial support from the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences the Netherlands, for supporting collaboration in HHT research with the University of California, San Francisco, the Helen Diller Family Comprehensive Cancer Center Abbreviations ACVRL1 = actvin A receptor type II-like 1 gene (ALK1) AVF = arteriovenous fistula AT = ataxia telangiectasia AVM = arteriovenous malformation BMP = bone-morphogenic-protein CAVM = cerebral arteriovenous malformation CM = capillary malformation CM-AVM = capillary malformation-arteriovenous malformation EC = endothelial cell ENG = endoglin GI = gastrointestinal HAVM = hepatic arteriovenous malformation HBT = hereditary benign telangiectasia HHT = hereditary hemorrhagic telangiectasia HHT1 = hereditary hemorrhagic telangiectasia type 1 (ENG) HHT2 = hereditary hemorrhagic telangiectasia type 2 (ACVRL1) HHT? = hereditary hemorrhagic telangiectasia, unknown genetic cause JP-HHT = juvenile polyposis and hereditary hemorrhagic telangiectasia MLPA = multiplex ligation-dependent probe amplification MNC = mononuclear cells MRI = magnetic resonance imaging PAH = pulmonary arterial hypertension PFO = patent foramen ovale PAVM = pulmonary arteriovenous malformation PH = pulmonary hypertension RLS = right-left shunt ROW = Rendu-Osler-Weber disease SMAD4 = mothers against decapentaplegic, drosophila, homolog of, 4 (MADH4) SMC = smooth muscle cells TGFβ = transforming growth factor beta TIA = transient ischemic attack Contents Chapter 1 General introduction 9 Chapter 2 Molecular genetic basis of hereditary hemorrhagic telangiectasia 25 Chapter 2.1 Hereditary hemorrhagic telangiectasia: ENG and ACVRL1 mutations in Dutch patients. 27 Hum Genet. 2005; 116: 8-16. Chapter 2.2 Multiplex Ligation-dependent Probe Amplification analysis identifies ENG and ACVRL1 deletions/duplications in hereditary hemorrhagic telangiectasia 45 submitted Chapter 2.3 SMAD4 mutations found in unselected HHT patients 55 J Med Genet. 2006; 43: 793-797. Chapter 3 Genotype – phenotype relationship in hereditary hemorrhagic telangiectasia 69 Chapter 3.1 Genotype-phenotype relationship in hereditary hemorrhagic telangiectasia. 71 J Med Genet. 2006; 43: 371-377. Chapter 3.2 Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. 87 Am J Med Genet A. 2008; 146:2733-2739. Chapter 3.3 The onset and severity of epistaxis in patients with ENG or ACVRL1 mutations 101 submitted Chapter 3.4 Assessment of intestinal vascular malformations in patients with hereditary hemorrhagic telangiectasia and anemia. 113 Eur J Gastroenterol Hepatol. 2007; 19: 153-158. Chapter 4 Discussion and perspective 127 Chapter 5 Summary 147 Nederlandse samenvatting 153 Dankwoord 159 Curriculum Vitae 163 List of publications 167 Chapter 1 General introducti on Genotype-phenotype relationship for localization and age distribution of telangiectases in HHT Genotype-phenotype relati onship for localizati on and age distributi on ofGeneral telangiectases introducti in on HHT 11 History Hereditary hemorrhagic telangiectasia (HHT) is also known by its eponym Rendu-Osler- 1 Weber disease (ROW) aft er the names of the fi rst physicians that described the disease. In 1896 Henry Jules Louis Marie Rendu published an arti cle on recurrent epistaxis in a pati ent with “peti ts angiomes cutanés et muqueux”. This was the fi rst complete descripti on of this disease. He was aware of its familial nature, its associati on with bleeding secondary to telangiectases, and its being an enti ty separate from hemophilia [1]. His paper was followed in 1901 by a report from William Osler and later in 1907 by one from Frederick Parkes Weber establishing the disease as an inherited disorder [2,3]. The term hereditary hemorrhagic telangiectasia was in 1909 proposed by Frank Hanes [4]. He advocated the name to be more in conformity with the medical nomenclature by referring to the three major clinical features. Despite the appropriateness and general usage of this descripti ve name, the eponym Rendu-Osler-Weber is sti ll widely used with the order of the names someti mes adapted, depending on the country of origin of the authors or on the appreciati on of the contributi on of the fi rst physicians. Hemorrhage of telangiectati c origin HHT was established as a disorder that primarily results in bleeding (e.g. nosebleeds or epistaxis) due to “inadequate vessels”, in which visceral involvement could occur and present in multi ple subjects in a family, in men as well as in women [2]. HHT is an autosomal dominant vascular disorder characterized by the presence of multi ple arteriovenous malformati ons (AVM). These AVMs are direct connecti ons between arteries and veins, thereby lacking the (normally) intervening capillary bed. Telangiectases are in fact small AVMs, which can present on the face, lips, tongue, fi ngers and in the nasal, oral and gastrointesti nal mucosa. AVMs in HHT usually refer to the larger arteriovenous connecti ons, commonly occurring in the lung (pulmonary arteriovenous malformati ons or PAVM), the brain (cerebral arteriovenous malformati ons or CAVM) and/or the liver (hepati c arteriovenous malformati ons or HAVM). These AVMs cause direct shunti ng of blood, resulti ng in the absence of normal capillary exchange and the absence of a normal capillary fi lter functi on [5]. Prevalence The prevalence of HHT varies considerably between countries and even between regions within a country. In part, this may be due to diff erences in ascertainment and diagnosis, but diff erences between populati ons truly exist, thought to be due to founder eff ects. As an example, in the Netherlands the frequency is esti mated to be 1-2:10,000, whereas in the Dutch Anti lles the prevalence is esti mated to be as high as 1:1,330 [6]. Also within-country 12 Chapter 1 General introduction regional variability has been documented: in some regions in France prevalence nears 1:3,500 [7]. Genetics of HHT Linkage studies on HHT families identified two major gene loci associated with HHT. In 1994, the ENG gene encoding endoglin was identified on chromosome 9q34 as the gene associated with HHT1 (MIM 187300) [8]. However, locus heterogeneity was obvious, since a number of families were not linked to chromosome 9 [9]. Two years later, in 1996, mutations in ACVRL1 (activin-like receptor kinase: ACVRL1 or ALK1) located on chromosome 12q13 were found to cause HHT2 (MIM 600376) [10]. Both genes encode proteins involved in the TGFβ pathway. The spectrum of mutations for both the ENG gene and the ACVRL1 gene consists of all kinds of mutations: missense, nonsense, frame shift, splice site etc. These mutations are typical for a loss of function. Mutations in HHT are collected in two major mutation databases (http://www.hhtmutation.org/ ; http:// www.hgmd.cf.ac.uk/ac/index.php). In January 2010, the Human Gene Mutation Database reported 316 mutations for the ENG gene; 100 missense/nonsense mutations, 134 insertions/deletions, 51 splice site mutations, 30 large deletions or duplications and 1 regulatory region mutation. For the ACVRL1 gene 273 different mutations are reported; 160 missense/nonsense mutations, 84 insertions/deletions, 20 splice site mutations and 9 large deletions/duplications. Protein expression studies in human umbilical vein endothelial cells and peripheral blood monocytes have confirmed haploinsufficiency, mutations that cause loss of function of one allele, as the main model in HHT1 and HHT2 [11-13]. SMAD4 has been implicated as a third gene involved in HHT. In 2004 Gallione et al.[14] reported mutations in the SMAD4 gene in a rare group of patients that show clinical features of two diseases: juvenile polyposis and HHT or JP-HHT (MIM 175050). The SMAD4 gene is located on chromosome 18q21.1, codes for the protein SMAD4 and is expressed in a variety of cell types. The protein, like ENG and ACVRL1, has a role in the TGFβ pathway as well as in the bone-morphogenic-protein (BMP) pathway. HHT as part of the JP-HHT syndrome can thus also be explained by SMAD4 mutations. Other candidate loci for HHT are linked to chromosome 5 and chromosome 7 [15,16]. These loci are now described as being responsible for HHT3 and HHT4 respectively. Cole et al.[16] described linkage to chromosome 5q31 in a family, in which linkage with ENG, ACVRL1 and SMAD4 was excluded and without mutations in any of these genes. They narrowed the linkage region on the chromosome down to 6 Mb with a maximum two point LOD score of 3.45. Bayrak-Toydemir et al.[15] excluded linkage to the HHT causing genes and detected a maximum two point LOD score of 3.6 with an STR marker on chromosome 7p14, in one family. They narrowed the region to 7 Mb. To date, no causative genes have been found in these two regions. General introducti on 13 The HHT1 gene: ENG The ENG gene (depicted in fi gure 1) is located on 9q33-q34.1 and encompasses approximately 1 40 kb of genomic DNA. The gene consists of 14 exons or 15 exons if the alternati ve splicing within the most distal exon is taken into considerati on. They respecti vely encode a longest mRNA of 3196 nt (NM_000118) and a shorter one with a length of 3072 nt (NM- 01114753).
Load more

Recommended publications
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • Craniosynostosis Genetics: the Mystery Unfolds
    Review Article Craniosynostosis genetics: The mystery unfolds Inusha Panigrahi Department of Pediatrics, Genetic and Metabolic Unit, Advanced Pediatric Center, PGIMER, Chandigarh, India The syndromes associated with craniosynostosis Craniosynsostosis syndromes exhibit considerable phenotypic and genetic heterogeneity. Sagittal synostosis include Apert syndrome, Crouzon syndrome, Greig is common form of isolated craniosynostosis. The cephalopolysyndactyly, and Saethre-Chotzen syndrome. sutures involved, the shape of the skull and associated malformations give a clue to the specific diagnosis. It is genetically heterogeneous disorder with mutation Crouzon syndrome is one of the most common of the identifi ed in several genes, predominantly the fi broblast craniosynostosis syndromes. Apert syndrome accounts for growth factor receptor genes.[3,4] Saethre-Chotzen 4.5% of all craniosynostoses and is one of the most serious of these syndromes. Most syndromic craniosynostosis syndrome and craniosynostosis (Boston-type) arise require multidisciplinary management. The following review from mutations in the Twist and muscle segment provides a brief appraisal of the various genes involved in craniosynostosis syndromes, and an approach to diagnosis homeobox 2 (MSX2) transcription factors, respectively. and genetic counseling. Rates of neuropsychological defi cits range from 35 to Key words: Apert syndrome, FGFR2 mutations, 50% in school-aged children with isolated single suture hydrocephalus, plagiocephaly, sutural synostosis, craniosynostosis.[5] Secondary effects of craniosynostosis syndromes may include vision problems and increased intracranial pressure, among others. Patients with TWIST gene Introduction mutations may have more ophthalmic abnormalities, including more strabismus, ptosis, and amblyopia.[6] The following discussion gives a comprehensive review Craniosynostosis, premature suture fusion, is one of of different disorders presenting with craniosynostosis, the most common craniofacial anomalies with incidence their diagnosis, and genetic counseling.
    [Show full text]
  • Blueprint Genetics Craniosynostosis Panel
    Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Genetic Disorder
    Genetic disorder Single gene disorder Prevalence of some single gene disorders[citation needed] A single gene disorder is the result of a single mutated gene. Disorder Prevalence (approximate) There are estimated to be over 4000 human diseases caused Autosomal dominant by single gene defects. Single gene disorders can be passed Familial hypercholesterolemia 1 in 500 on to subsequent generations in several ways. Genomic Polycystic kidney disease 1 in 1250 imprinting and uniparental disomy, however, may affect Hereditary spherocytosis 1 in 5,000 inheritance patterns. The divisions between recessive [2] Marfan syndrome 1 in 4,000 and dominant types are not "hard and fast" although the [3] Huntington disease 1 in 15,000 divisions between autosomal and X-linked types are (since Autosomal recessive the latter types are distinguished purely based on 1 in 625 the chromosomal location of Sickle cell anemia the gene). For example, (African Americans) achondroplasia is typically 1 in 2,000 considered a dominant Cystic fibrosis disorder, but children with two (Caucasians) genes for achondroplasia have a severe skeletal disorder that 1 in 3,000 Tay-Sachs disease achondroplasics could be (American Jews) viewed as carriers of. Sickle- cell anemia is also considered a Phenylketonuria 1 in 12,000 recessive condition, but heterozygous carriers have Mucopolysaccharidoses 1 in 25,000 increased immunity to malaria in early childhood, which could Glycogen storage diseases 1 in 50,000 be described as a related [citation needed] dominant condition. Galactosemia
    [Show full text]
  • Original Articles Evidence for Digenic Inheritance in Some Cases of Antley
    26 J Med Genet 2000;37:26–32 Original articles J Med Genet: first published as 10.1136/jmg.37.1.26 on 1 January 2000. Downloaded from Department of Clinical Genetics, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK Evidence for digenic inheritance in some cases of W Reardon M Baraitser Antley-Bixler syndrome? R M Winter Molecular Genetics Unit, Institute of Child Health, London, UK William Reardon, Anne Smith, John W Honour, Peter Hindmarsh, Debipriya Das, A Smith Gill Rumsby, Isabelle Nelson, Sue Malcolm, Lesley Adès, David Sillence, I Nelson Dhavendra Kumar, Celia DeLozier-Blanchet, Shane McKee, Thaddeus Kelly, S Malcolm Wallace L McKeehan, Michael Baraitser, Robin M Winter Department of Chemical Pathology, University College London Hospitals, London, UK J W Honour Abstract The Antley-Bixler syndrome represents the D Das The Antley-Bixler syndrome has been severe end of the spectrum of syndromic G Rumsby thought to be caused by an autosomal craniosynostosis. Many such patients have London Centre for recessive gene. However, patients with this choanal atresia and severe respiratory distress, Paediatric often resulting in early death. In contrast with Endocrinology, phenotype have been reported with a new University College dominant mutation at the FGFR2 locus as most clinically similar forms of syndromic Hospital, London, UK well as in the oVspring of mothers taking craniosynostosis, which are transmitted in an P Hindmarsh the antifungal agent fluconazole during autosomal dominant manner, Antley-Bixler Departments of early pregnancy. In addition to the cranio- syndrome has been thought to be an autosomal Clinical Genetics and recessive disorder.7 This is based upon three Paediatrics and Child synostosis and joint ankylosis which are the 8–10 Health, New Children’s clinical hallmarks of the condition, many reports of aVected sibs and the birth of Hospital, Parramatta, patients, especially females, have genital aVected subjects to consanguineous par- NSW 2124, Australia ents.91112It should be noted that joint ankylo- abnormalities.
    [Show full text]
  • Anesthesia Management of Jansen's Metaphyseal Dysplasia
    CASE REPORT East J Med 21(1): 52-53, 2016 Anesthesia management of Jansen’s metaphyseal dysplasia Ugur Goktas1,*, Murat Tekin2, Ismail Kati3 1Department of Anesthesiology, Medical Faculty, Yuzuncu Yil University, Van, Turkey 2Department of Anesthesiology, Medical Faculty, Kocaeli University, Kocaeli, Turkey 3Department of Anesthesiology, Medical Faculty, Gazi University, Ankara, Turkey ABSTRACT Metaphyseal chondrodysplasia is a rare autosomal dominant disorder characterized by accumulation of cartilage in specifically metaphysis of tubular bones. Hyperkalemia and hypophosphatemia were seen most of these patients. In this article we intended to draw attention to some issues releated with anesthesia hereby that a 9 year-old patient with Jansen’s metaphyseal dysplasia. Key Words: general anesthesia, congenital anomalies, drugs Introduction (60%) were used for the anesthesia management. Operation duration was 50 min. LMA was removed Metaphyseal chondrodysplasia is a very rare postoperatively without any problem. Control serum autosomal dominant disorder affected of enchondral potassium and phosphor levels peroperatively and ossification in especially metaphysis (1). Firstly postoperatively were found normal (Table 1). After described in 1934 by Murk Jansen as various severity the recovery patient was sent to the ward without any and degrees (2), and metaphyseal chondrodysplasia problem. was classified in 1957 by Weil. Jansen type, which is the one of the most serious and rare. Hyperkalemia Discussion and hypophosphatemia were seen half of these Jansen type metaphyseal dysplasia is a very rare patients (3,4). In this article we intended to draw and serious disorder in the enchondral ossification attention to some issues related with anesthesia diseases. Affecting the metaphyses such as management that a 9 year-old patient a with Jansen’s achondroplasia, various types of rickets, metaphyseal dysplasia which to be a disorder very rare hypophosphatasia and multiple enchondromatosis and hardest diagnosing.
    [Show full text]
  • Vistara Non-Invasive Prenatal Screen
    Vistara non-invasive prenatal screen Hypochondro- Causes a mild form of dwarsm; up to 80% Vistara identies probability for conditions that may have otherwise gone undetected until after birth plasia may cause seizures with secondary or into childhood. All conditions are inherited in an autosomal or X-linked dominant fashion, which means that FGFR3 developmental delay if the mutation is present, the child will be affected by the condition and experience related symptoms. Intellectual Causes intellectual disability and ~100% disability developmental delays SYNGAP1 Condition1 Clinical Cases Ultrasound ndings2,3 Clinical Detection Gene(s) synopsis2,3 caused by actionability rate for Jackson Weiss A type of craniosynostosis; more de novo None Third Non- gene1 syndrome also causes foot abnormalities severe mutations2,3 trimester specic FGFR2 forms Achondroplasia The most common form 80% Labor and delivery >96% FGFR3 of skeletal dysplasia; may management, monitor Juvenile A rare pediatric blood cancer; ve- unknown cause hydrocephalus, for spinal stenosis, early myelomonocytic year survival is approximately 50% delayed motor milestones, sleep studies to reduce leukemia (JMML) and spinal stenosis risk of SIDS PTPN11 Alagille Affects multiple organ systems 50% to 70% Symptom-based >86% LEOPARD Similar to Noonan syndrome, unknown syndrome and may cause growth problems, treatment syndrome 1,2 with notable brown skin spots JAG1 congenital heart defects, and (Noonan (lentigines); causes short stature, vertebral differences syndrome heart defects, bleeding
    [Show full text]
  • Musculoskeletal Block Pathology Lecture 2
    MUSCULOSKELETAL BLOCK PATHOLOGY LECTURE 2: CONGENITAL AND DEVELOPMENTAL BONE DISEASES Prepared by Dr. Maha Arafah Given by:Dr.Amany Fathaddin 2014 Diseases of Bones Objectives Be aware of some important congenital and developmental bone diseases and their principal pathological features Be familiar with the terminology used in some important developmental and congenital disorders. Understand the etiology, pathogenesis and clinical features of osteoporosis Bone 206 bones organic matrix (35%) and inorganic elements (65%): calcium hydroxyapatite [Ca10(PO4)6(OH)2] The bone-forming cells include osteoblasts and osteocytes, while cells of the bone-digesting lineage are osteoclasts is very dynamic and subject to constant breakdown and renewal: remodeling Diseases of Bones Congenital Acquired Metabolic Infections Traumatic Tumors Congenital Diseases of Bones Localized or entire skeleton Developmental anomalies resulting from Dysostoses: e.g. localized problems in the migration of aplasia mesenchymal cells and the formation of extra bones condensations abnormal fusion of bones Dysplasias: e.g. Osteogenesis imperfecta Achondroplasia Osteopetrosis Osteogenesis imperfecta Congenital Diseases of Bones Osteogenesis imperfecta (brittle bone disease) Osteogenesis imperfecta is a group of inherited diseases characterized by brittle bones Defect in the synthesis of type I collagen leading to too little bone resulting in extreme skeletal fragility with susceptibility to fractures Four main types with different clinical manifestations classified according to the severity of bone fragility, the presence or absence of blue scleras, hearing loss, abnormal dentition, and the mode of inheritance, some are fatal. Type 1: blue sclera in both eye, deformed teeth and hearing loss Osteogenesis imperfecta, type 1 blue scleras brittle bones deformed teeth Osteogenesis imperfecta Skeletal radiograph of a fetus with lethal type 2 osteogenesis imperfecta Achondroplasia Achondroplasia is the most common skeletal dysplasia and a major cause of dwarfism.
    [Show full text]
  • EUROCAT Syndrome Guide
    JRC - Central Registry european surveillance of congenital anomalies EUROCAT Syndrome Guide Definition and Coding of Syndromes Version July 2017 Revised in 2016 by Ingeborg Barisic, approved by the Coding & Classification Committee in 2017: Ester Garne, Diana Wellesley, David Tucker, Jorieke Bergman and Ingeborg Barisic Revised 2008 by Ingeborg Barisic, Helen Dolk and Ester Garne and discussed and approved by the Coding & Classification Committee 2008: Elisa Calzolari, Diana Wellesley, David Tucker, Ingeborg Barisic, Ester Garne The list of syndromes contained in the previous EUROCAT “Guide to the Coding of Eponyms and Syndromes” (Josephine Weatherall, 1979) was revised by Ingeborg Barisic, Helen Dolk, Ester Garne, Claude Stoll and Diana Wellesley at a meeting in London in November 2003. Approved by the members EUROCAT Coding & Classification Committee 2004: Ingeborg Barisic, Elisa Calzolari, Ester Garne, Annukka Ritvanen, Claude Stoll, Diana Wellesley 1 TABLE OF CONTENTS Introduction and Definitions 6 Coding Notes and Explanation of Guide 10 List of conditions to be coded in the syndrome field 13 List of conditions which should not be coded as syndromes 14 Syndromes – monogenic or unknown etiology Aarskog syndrome 18 Acrocephalopolysyndactyly (all types) 19 Alagille syndrome 20 Alport syndrome 21 Angelman syndrome 22 Aniridia-Wilms tumor syndrome, WAGR 23 Apert syndrome 24 Bardet-Biedl syndrome 25 Beckwith-Wiedemann syndrome (EMG syndrome) 26 Blepharophimosis-ptosis syndrome 28 Branchiootorenal syndrome (Melnick-Fraser syndrome) 29 CHARGE
    [Show full text]
  • The Differential Diagnosis of the Short-Limbed Dwarfs Presenting at Birth R
    Postgrad Med J: first published as 10.1136/pgmj.53.618.204 on 1 April 1977. Downloaded from Postgraduate Medical Journal (April 1977) 53, 204-211 The differential diagnosis of the short-limbed dwarfs presenting at birth R. N. MUKHERJI P. D. Moss M.R.C.P., D.C.H. F.R.C.P., D.C.H. Department ofPaediatrics, Royal Infirmary, Blackburn, Lancashire Summary Harris and Patton (1971) reviewed seventeen still- Attention is drawn to the fact that in a number of born or early neonatal deaths originally diagnosed types of short-limbed dwarfism a precise diagnosis can as achondroplastics and showed that in ten of these be made in the neonatal period. Examples are given cases the diagnosis should have been thanatophoric and the prognostic and genetic implications are dis- dwarfism. This supports the view that achondro- cussed. It is important to be able to advise parents of plasia has been over diagnosed at birth and that the the likely outlook for the infant and of the genetic severely affected cases are, in fact, some other type implication. Early diagnosis is therefore not merely of lethal neonatal dwarfism. an academic exercise. Achondrogenesis Introduction This was first described under the title of anosteo- When Rathbun (1948) first described neonatal genesis (Parenti, 1936) as it was thought to be a hypophosphatasia he discussed three conditions of variety of osteogenesis imperfecta. Fraccaro (1952) differential diagnosis. These consisted ofosteogenesis first used the term 'achondrogenesis' because of by copyright. imperfecta, achondroplasia and renal hyperpara- marked retardation of ossification. Parental con- thyroidism. Since then a number of other conditions sanguinity (Saldino, 1971) and multiple affected have been defined on a clinical, radiological and siblings (Houston, Awen and Kent, 1972) have been genetic basis (Tables 1 and 2).
    [Show full text]
  • Achondroplasia and Spinal Cord Lesion. Three Case Reports
    Paraplegia 31 (1993) 375-379 © 1993 International Medical Society of Paraplegia Achondroplasia and spinal cord lesion. Three case reports N Hamamci MD, * S Hawran MD, F Biering-Sprensen MD PhD Centre for Spinal Cord Injured, Rigshospitalet, National University Hospital, Copenhagen, Denmark. The most important complications encountered by achondroplastic dwarfs are neurological problems related to a narrowed spinal canal. Stenosis of the spinal canal is secondary to abnormalities of endochondral ossification with premature synostosis of the ossification centres of the vertebral body and the posterior arch, resulting in thickening of the lamina, shortening of the pedicles, and reduced height of the vertebral bodies. Additional factors such as prolapsed intervertebral discs, osteophytes and progressive thoracolumbar kyphosis con­ tribute to the narrowing of the spinal canal. Three achondroplastic dwarfs having spinal stenosis and spinal cord lesion representing typical clinical courses are described. Keywords: achondroplasia; dwarfism; spinal cord injury; spinal canal stenosis. Introduction and the vertebral bodies reduced in height. Thus the spinal canal is narrowed both Achondroplasia, the most common form of anteroposteriorly and transversely (Fig 1). osteochondrodysplasia, is autosomal domin­ The spinal subarachnoid space is further ant with most cases being new mutations. It reduced because the vertebral bodies are is characterised by rhizomelic shortness of concave in their posterior aspect with the the limbs, midface hypoplasia and defective upper and lower surfaces projecting into the endochondral bone development. 1-3 space of the vertebral canal. 3 There is a high incidence of neural This report describes three achondro­ complications associated with this form of plastic dwarfs suffering from spinal stenosis dwarfism.4 Neural complications are pres­ and incomplete SCI who were admitted to ent in about 50% of the patients and include our centre within a period of 3 years.
    [Show full text]